Radiation InjuriesRadiation DosageRadiotherapyRadiotherapy DosageRadiation, IonizingDose-Response Relationship, RadiationCombined Modality TherapyRadiotherapy, ConformalRadiation ToleranceRadiotherapy, Intensity-ModulatedRadiation OncologyDose FractionationRadiotherapy, AdjuvantRadiotherapy Planning, Computer-AssistedRadiationBrachytherapyRadiation ProtectionProstatic NeoplasmsRadiation PneumonitisRadiosurgeryNeoplasm Recurrence, LocalRadiation MonitoringNeoplasms, Radiation-InducedTreatment OutcomeBreast NeoplasmsRadiometryNeoplasm StagingRadiotherapy, Computer-AssistedHead and Neck NeoplasmsCranial IrradiationRadiation-Sensitizing AgentsLung NeoplasmsBrain NeoplasmsRadiotherapy, Image-GuidedRetrospective StudiesSurvival AnalysisNeoplasmsAntineoplastic Combined Chemotherapy ProtocolsSurvival RateCarcinoma, Squamous CellParticle AcceleratorsFollow-Up StudiesDisease-Free SurvivalEarly Detection of CancerPrognosisRadiotherapy, High-EnergyOrgans at RiskChemotherapy, AdjuvantRadiation Injuries, ExperimentalRadiodermatitisGamma RaysAntineoplastic AgentsNeoplasm MetastasisChemoradiotherapyAdenocarcinomaRectal NeoplasmsTumor BurdenMastectomy, SegmentalPancreatic NeoplasmsCisplatinCarcinoma, Non-Small-Cell LungTomography, X-Ray ComputedProstate-Specific AntigenUterine Cervical NeoplasmsRadiation-Protective AgentsCosmic RadiationFluorouracilNeoplasm InvasivenessOvarian NeoplasmsMice, NudeNeoplasms, Second PrimaryCarcinomaTime FactorsColonic NeoplasmsProspective StudiesStomach NeoplasmsCobalt RadioisotopesMastectomyCell Line, TumorSEER ProgramActuarial AnalysisKaplan-Meier EstimateAndrogen AntagonistsLymphatic IrradiationFour-Dimensional Computed TomographySurvivorsGene Expression Regulation, NeoplasticBackground RadiationDisease ProgressionRisk AssessmentRiskGlioblastomaRadiobiologyXenograft Model Antitumor AssaysProstatectomyClinical Trials as TopicCell SurvivalEsophageal NeoplasmsCancer VaccinesUltraviolet Rays